间质性肺异常的评估与管理:ATS临床声明
美国胸科学会专家组通过视频会议共识定义间质性肺异常(ILA)与间质性肺病(ILD),并就11个预设问题投票形成建议。声明更新了Fleischner学会ILA定义,取消对高风险人群的排除,提出ILA与ILD的区分标准,并给出筛查、评估与随访建议。
要点
- ILA定义为CT上非依赖区双肺实质异常累及≥5%的肺区。
- ILD与ILA的区分依据症状、肺功能异常或下降、纤维化或进展性影像及特定纤维化模式。
- 建议对肺癌筛查影像评估ILA/ILD,对结缔组织病成人及家族性肺纤维化患者一级亲属筛查,ILA每2-3年复查胸部CT。
核心结论
- 声明更新了Fleischner学会ILA定义,建立工作性ILD定义,并为ILA评估与管理提供循证建议。
研究设计与样本
- 临床与方法学专家委员会通过视频会议共识定义ILA与ILD,审阅系统文献检索证据后就11个预设问题投票,每个建议需≥70%同意。
主要发现
- ILA定义为CT上非依赖区双肺实质异常,包括磨玻璃影或网格影、肺扭曲、牵拉性支气管扩张和/或蜂窝,累及≥5%的肺区。
- 更新定义取消了先前对高风险人群的排除。
- ILD与ILA的区分依据:可归因于间质过程的症状(呼吸困难/咳嗽)、肺功能异常或下降、纤维化(蜂窝和/或网格影伴牵拉性支气管扩张累及≥5%总肺体积)或进展性影像异常、和/或影像或病理上的特定纤维化ILD模式。
关键数值与推荐
- ILA累及≥5%的肺区;纤维化影像异常累及≥5%总肺体积;建议每个建议需≥70%同意;建议ILA每2-3年复查胸部CT。
临床怎么用
- 对肺癌筛查所获影像评估ILA/ILD;筛查结缔组织病成人及家族性肺纤维化患者的一级亲属;对ILA者评估基线症状与肺功能;对ILA每2-3年复查胸部CT监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: There is growing interest in identifying early stages of interstitial lung disease (ILD) to improve patient outcomes. This document reviews updated evidence on interstitial lung abnormalities (ILAs); provides suggestions for screening, evaluation, and management; proposes criteria for distinguishing ILAs from ILD; and identifies research priorities. Methods: A committee of clinical and methodology experts met by video conference to define ILAs and ILD by consensus and voted on 11 prespecified questions after reviewing synthesized evidence from a systematic literature search. Agreement of ≥70% was required to approve each suggestion. Results: ILA is defined as nondependent bilateral parenchymal abnormalities on computed tomography, including ground-glass opacities or reticulations, lung distortion, traction bronchiectasis, and/or honeycombing involving ≥5% of a lung zone. The updated definition removes the prior exclusion of high-risk populations. ILD is distinguished from ILAs by symptoms (dyspnea/cough) attributable to an interstitial process, abnormal or declining lung function, fibrotic (honeycombing and/or reticulation with traction bronchiectasis involving ≥5% of total lung volume) or progressive imaging abnormalities, and/or specific fibrotic ILD patterns on imaging or pathology. Suggestions include ILA/ILD assessment on imaging acquired for lung cancer screening, screening adults with connective tissue disease and first-degree relatives of patients with familial pulmonary fibrosis, assessing baseline symptoms and pulmonary function among those with ILAs, and monitoring ILAs with chest computed tomography every 2-3 years. Conclusions: This document presents a comprehensive literature review of ILAs with updates to the Fleischner Society ILA definition, establishes a working ILD definition, and provides evidence-based suggestions for ILA evaluation and management.
引用
- Podolanczuk AJ, Hunninghake GM, Wilson KC, et al. Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement. Am J Respir Crit Care Med. 2025. PMID: 40387336. doi:10.1164/rccm.202505-1054ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。